Company news
Microbot Medical Inc. (NASDAQ:MBOT) news
Microbot Medical Inc. news releases on 6ix. Latest, Jul 11, 2023: Microbot Medical Expands its Physician Support with the Addition of Leading Italian…
Press releases — page 3
Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board
July 10, 2023
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
June 28, 2023
Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings
June 27, 2023
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 26, 2023
Microbot Medical Expand IP protection in Japan
June 21, 2023
Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe
June 15, 2023
Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System
June 1, 2023
Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 1, 2023
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
May 22, 2023
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
May 21, 2023
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
May 21, 2023
Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases
May 17, 2023
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
May 7, 2023
Microbot Medical Announces Final Data From Its Recent Animal Study
May 4, 2023
Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization
May 2, 2023
Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to Acce...
March 15, 2023
Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System
March 1, 2023
Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board
February 26, 2023
Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan
February 22, 2023
Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series
January 30, 2023
Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series
December 13, 2022
Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel
December 7, 2022
Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance
November 17, 2022
Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System
November 2, 2022
Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board
October 30, 2022
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
October 20, 2022
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
October 12, 2022
Microbot Medical Enhances Strategic Focus on its Endovascular Solutions
October 10, 2022
Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System
October 9, 2022
Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
October 6, 2022
Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment
October 3, 2022
Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi
September 18, 2022
Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal
September 14, 2022
Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System
September 11, 2022
Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System
September 5, 2022
Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month
September 1, 2022
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
April 5, 2022
Microbot Medical Achieves Significant Regulatory Milestone for the LIBERTY® Robotic System; Files FDA Pre-Submission Package for Regulatory Pathway
March 30, 2022
Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications
December 26, 2021
Microbot Medical Secures Third Patent for the LIBERTY® Robotic System in the United States; Success of Protecting Novel Intellectual Property Complements Recent Design Freeze Achievement
December 22, 2021
Microbot Medical Initiates Search for U.S. Clinical Sites for the LIBERTY® Robotic System
December 21, 2021
Microbot Medical Achieves Design Freeze of the LIBERTY® Robotic System; Meets Previously Stated Milestone Timeline
December 14, 2021
Microbot Medical Secures Additional Patent for the LIBERTY® Robotic System in the United States
November 18, 2021
Microbot Medical Secures Patent for LIBERTY® Robotic System in the United States
October 5, 2021
Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ‘One & Done’ Technology
June 28, 2021
Leading Interventional Cardiologist Dr. Giora Weisz Joins Microbot Medical’s Scientific Advisory Board
June 6, 2021
Microbot Medical Secures Additional Protection for the One & Done Guidewire Technology with another Notice of Patent Allowance
June 3, 2021
Microbot Medical Granted Patent Allowance in Japan; Global Jurisdictions Recognizing Novel ‘One & Done’ Technology
February 3, 2021
Microbot Medical Announces Successful Outcome of its Discussions with FDA Regarding Regulation of Self-Cleaning Shunt
January 26, 2021
Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional Radiologists
January 20, 2021